Monday's Final Takeaways: PFE Buying MTSR, China ADRs & Port Fees

While the A.I. trade and Trump's knock on health insurers took a lot of market attention in Monday's session, Marley Kayden and Sam Vadas turn to other stories behind today's moves. Healthcare saw another big headline in Pfizer's (PFE) bid for Metsera (MTSR) while international traders had their eyes on China.

Market On Close

10 Nov 2025

SHARE

Schwab Network's Newsletters

Daily insights for every investor